ELANCO ANIMAL HEALTH INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.35 USD | -3.30% |
|
-4.23% | -10.40% |
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
Pharmaceuticals
Calendar
2024-08-04
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
13.35
USD
Average target price
19.21
USD
Spread / Average Target
+43.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.40% | 6.6B | |
| +35.00% | 3.99B | |
| +2.64% | 3.38B | |
| +21.62% | 1.76B | |
| -1.95% | 1.28B | |
| -39.28% | 1.01B | |
| -43.09% | 950M | |
| -19.34% | 843M | |
| -36.21% | 833M | |
| -13.55% | 794M |
- Stock Market
- Equities
- ELAN Stock
- News Elanco Animal Health Incorporated
- Elanco Canine Dermatitis Treatment Will Carry Cautionary Labelling -- Shares Drop
